A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease
A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease
The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.
Inclusion Criteria:
Exclusion Criteria:
Capital Federal, Buenos Aires 1181, Argentina
Ciudad de Buenos Aires, Buenos Aires 1221, Argentina
Pireaus, 18526, Greece
Zuthpen, 7207 BA, Netherlands
Tau-Yuan Hsien, 333, Taiwan